NM_172107.4:c.*5962G>T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_172107.4(KCNQ2):​c.*5962G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.222 in 398,554 control chromosomes in the GnomAD database, including 11,536 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.19 ( 3529 hom., cov: 33)
Exomes 𝑓: 0.24 ( 8007 hom. )

Consequence

KCNQ2
NM_172107.4 3_prime_UTR

Scores

7

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.511

Publications

10 publications found
Variant links:
Genes affected
KCNQ2 (HGNC:6296): (potassium voltage-gated channel subfamily Q member 2) The M channel is a slowly activating and deactivating potassium channel that plays a critical role in the regulation of neuronal excitability. The M channel is formed by the association of the protein encoded by this gene and a related protein encoded by the KCNQ3 gene, both integral membrane proteins. M channel currents are inhibited by M1 muscarinic acetylcholine receptors and activated by retigabine, a novel anti-convulsant drug. Defects in this gene are a cause of benign familial neonatal convulsions type 1 (BFNC), also known as epilepsy, benign neonatal type 1 (EBN1). At least five transcript variants encoding five different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
KCNQ2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 7
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • neonatal encephalopathy with non-epileptic myoclonus
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neonatal-onset developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • seizures, benign familial neonatal, 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • seizures, benign familial neonatal, 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • benign familial infantile epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • benign familial neonatal-infantile seizures
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • benign neonatal seizures
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • malignant migrating partial seizures of infancy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0012863576).
BP6
Variant 20-63400682-C-A is Benign according to our data. Variant chr20-63400682-C-A is described in ClinVar as Benign. ClinVar VariationId is 3255266.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.414 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNQ2NM_172107.4 linkc.*5962G>T 3_prime_UTR_variant Exon 17 of 17 ENST00000359125.7 NP_742105.1 O43526-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNQ2ENST00000359125.7 linkc.*5962G>T 3_prime_UTR_variant Exon 17 of 17 1 NM_172107.4 ENSP00000352035.2 O43526-1

Frequencies

GnomAD3 genomes
AF:
0.189
AC:
28752
AN:
152128
Hom.:
3519
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0450
Gnomad AMI
AF:
0.194
Gnomad AMR
AF:
0.259
Gnomad ASJ
AF:
0.252
Gnomad EAS
AF:
0.429
Gnomad SAS
AF:
0.322
Gnomad FIN
AF:
0.280
Gnomad MID
AF:
0.199
Gnomad NFE
AF:
0.216
Gnomad OTH
AF:
0.195
GnomAD4 exome
AF:
0.243
AC:
59776
AN:
246310
Hom.:
8007
Cov.:
0
AF XY:
0.243
AC XY:
30286
AN XY:
124834
show subpopulations
African (AFR)
AF:
0.0439
AC:
315
AN:
7180
American (AMR)
AF:
0.299
AC:
2219
AN:
7432
Ashkenazi Jewish (ASJ)
AF:
0.263
AC:
2427
AN:
9232
East Asian (EAS)
AF:
0.424
AC:
9708
AN:
22892
South Asian (SAS)
AF:
0.332
AC:
1008
AN:
3040
European-Finnish (FIN)
AF:
0.275
AC:
5724
AN:
20836
Middle Eastern (MID)
AF:
0.221
AC:
286
AN:
1294
European-Non Finnish (NFE)
AF:
0.217
AC:
34272
AN:
158034
Other (OTH)
AF:
0.233
AC:
3817
AN:
16370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
3091
6182
9272
12363
15454
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
204
408
612
816
1020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.189
AC:
28770
AN:
152244
Hom.:
3529
Cov.:
33
AF XY:
0.196
AC XY:
14575
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.0449
AC:
1866
AN:
41578
American (AMR)
AF:
0.259
AC:
3959
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.252
AC:
875
AN:
3470
East Asian (EAS)
AF:
0.429
AC:
2216
AN:
5168
South Asian (SAS)
AF:
0.323
AC:
1560
AN:
4828
European-Finnish (FIN)
AF:
0.280
AC:
2970
AN:
10606
Middle Eastern (MID)
AF:
0.192
AC:
56
AN:
292
European-Non Finnish (NFE)
AF:
0.216
AC:
14664
AN:
67992
Other (OTH)
AF:
0.202
AC:
427
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1140
2281
3421
4562
5702
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
320
640
960
1280
1600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.209
Hom.:
4759
Bravo
AF:
0.182
TwinsUK
AF:
0.186
AC:
688
ALSPAC
AF:
0.194
AC:
747
Asia WGS
AF:
0.373
AC:
1295
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Benign:1
Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 57% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 53. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.81
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
1.5
DANN
Benign
0.83
FATHMM_MKL
Benign
0.069
N
LIST_S2
Benign
0.38
T
MetaRNN
Benign
0.0013
T
PhyloP100
0.51
Vest4
0.11
MVP
0.36
GERP RS
3.3

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3746372; hg19: chr20-62032035; API